KB407’s positive set of results presented at ATS 2026 follows a set of similar positive results that were announced for the ...
CF carrier screening shows reduced accuracy in non-European groups. Learn how CFTR variant panels affect equity and find out ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) is a combination medicine approved by the FDA in 2024. Alyftrek is approved to treat people ages 6 and older who have ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers have succeeded in developing a so-called nanobody that penetrates directly ...
Cystic fibrosis, or CF, is a lifelong genetic condition that affects how the body produces mucus, sweat, and digestive fluids. More than 100,000 people across 94 countries have been diagnosed with ...
Please provide your email address to receive an email when new articles are posted on . Patients given aerosolized 4D-710 had elevated CFTR protein levels that went over normal levels. Over 12 months, ...
Sionna Therapeutics, Inc. has announced the presentation of promising preclinical data at the 48th European Cystic Fibrosis Conference in Milan, showing that its nucleotide-binding domain 1 (NBD1) ...
To generate mice expressing CFTR specifically in ciliated cells, the EGFP cDNA in the previously described FOXJ1 construct 15 was replaced with the cDNA for human CFTR. 17 Transgenic mice were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results